NCT02817633 2025-10-28A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)Tesaro, Inc.Phase 1 Active not recruiting463 enrolled
NCT05456685 2025-10-28Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian CancerAbbViePhase 2 Active not recruiting125 enrolled
NCT05599984 2025-10-20Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid TumorsAbbViePhase 1 Active not recruiting288 enrolled
NCT03893955 2025-08-12A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsAbbViePhase 1 Active not recruiting150 enrolled
NCT05704985 2025-05-29Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA BiosciencesPhase 1 Active not recruiting39 enrolled
NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT03530397 2024-06-24A Study to Evaluate MEDI5752 in Subjects With Advanced Solid TumorsMedImmune LLCPhase 1 Active not recruiting401 enrolled